No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Lobe Sciences Ltd: MDA EN
Lobe Sciences Ltd: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin
Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin
Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team